Pro re nata anti-VEGF treatment in pachychoroid neovasculopathy compared with age-related macular degeneration based on optical coherence tomography
International Ophthalmology · 2024
DOI: 10.1007/s10792-024-03094-w ↗Kurz gefasst
Fachartikel in der Zeitschrift International Ophthalmology, 2024. Verfasst von Güner Üney und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ankara Training and Research Hospital, University of Health Sciences, Hacettepe Mh. Ulucanlar Cd. No: 89, 06230, Altındağ, Ankara, Turkey. guner_ozka…. Hauptthemen laut MEDLINE: Ranibizumab, Macular Degeneration. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ankara Training and Research Hospital, University of Health Sciences, Hacettepe Mh. Ulucanlar Cd. No: 89, 06230, Altındağ, Ankara, Turkey. guner_ozkan@yahoo.com.
- Ankara Training and Research Hospital, University of Health Sciences, Hacettepe Mh. Ulucanlar Cd. No: 89, 06230, Altındağ, Ankara, Turkey.
Zitieren
APA
Üney, G., Hazırolan, D., Ünlü, N., & Candan, Ö. (2024). Pro re nata anti-VEGF treatment in pachychoroid neovasculopathy compared with age-related macular degeneration based on optical coherence tomography. International Ophthalmology. https://doi.org/10.1007/s10792-024-03094-w
Vancouver
Üney G, Hazırolan D, Ünlü N, Candan Ö. Pro re nata anti-VEGF treatment in pachychoroid neovasculopathy compared with age-related macular degeneration based on optical coherence tomography. International Ophthalmology. 2024. doi:10.1007/s10792-024-03094-w
BibTeX
@article{ney2024,
author = {Üney, Güner and Hazırolan, Dicle and Ünlü, Nurten and Candan, Özlem},
title = {Pro re nata anti-VEGF treatment in pachychoroid neovasculopathy compared with age-related macular degeneration based on optical coherence tomography},
journal = {International Ophthalmology},
year = {2024},
doi = {10.1007/s10792-024-03094-w}
}
EUVIMED